Spots Global Cancer Trial Database for Dose-Finding Study of E7070 in Combination With Irinotecan
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dose-Finding Study of E7070 in Combination With Irinotecan
Official Title: Phase I Dose-Finding Study of E7070 in Combination With Irinotecan
Study ID: NCT00060567
Conditions
Study Description
Brief Summary: E7070 and irinotecan will be administered to patients with GI tract, pancreatic or lung tumors on Days 1 and 8 of a 21-day cycle, or Days 1 and 15 of a 28-day cycle according to one of two E7070 dose escalation schemes.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Boston, Massachusetts, United States
Contact Details
Name: Eisai Medical Services
Affiliation: Eisai Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
